MicroRNAs in cardiovascular disease.

Area of Science:

• Cardiovascular Biology
• Molecular Biology
• Genetics

Background:

• Noncoding RNAs, particularly microRNAs (miRNAs), play critical roles in cardiovascular biology.
• These molecules are increasingly recognized as potential therapeutic targets for cardiovascular diseases.

Purpose of the Study:

• To review and highlight recent discoveries concerning the role of microRNAs in cardiovascular biology.
• To explore the therapeutic potential of targeting miRNAs in cardiovascular conditions.

Main Methods:

• Literature review of current research on microRNAs in cardiovascular biology.
• Analysis of studies investigating miRNA function in cardiac development, hypertrophy, fibrosis, and regeneration.
• Examination of evidence for pharmacological interventions targeting miRNAs.

Main Results:

• miRNAs regulate posttranscriptional gene expression, impacting cardiac development, hypertrophy, fibrosis, and regeneration.
• Specific miRNAs (e.g., miR-25, miR-22, miR-302-367, miR99/100 families, miR-125b) are identified as key regulators of cardiac contractility, regeneration, and fibrosis.
• Pharmacological interventions using anti-miRNA oligonucleotides have demonstrated efficacy in improving cardiac contractility and reducing fibrosis in heart failure models.

Conclusions:

• miRNAs are essential regulators of cardiac phenotype, attracting significant interest from both basic scientists and clinicians.
• Advancements in technology and understanding of miRNA deregulation mechanisms position the field at a critical juncture for therapeutic development.
• Modulating miRNA function holds significant promise for future cardiovascular therapeutics.